$FHTX Cashflow Statement | Understand Stock

$FHTX

$2.05 +$0.00 (0.0%) Close

$FHTX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense
Depreciation and amortization expense
Loss on disposal of property and equipment
Loss on debt extinguishment
Change in fair value of preferred stock warrant liability
Gain on lease modification
Impairment of long-lived assets
Noncash interest expense
Noncash lease expense
Accretion of discount on marketable securities
Changes in operating assets and liabilities:
Prepaid expenses and other current assets
Collaboration receivable
Accounts payable
Accrued expenses and other liabilities
Operating lease liabilities
Deferred revenue

Net cash used in operating activities
Cash flows from investing activities:
Purchases of property and equipment
Proceeds from sale of property and equipment
Purchases of marketable securities
Proceeds from maturities of marketable securities
Net cash provided by (used in) investing activities

Cash flows from financing activities:
Proceeds from stock purchase agreement
Proceeds from initial public offering, net of underwriting discounts, commissions and offering costs
Proceeds from issuance of convertible preferred stock, net of issuance costs
Proceeds from offerings of common stock and pre-funded warrants, net of underwriting discounts and commissions
Prefunded Warrants
At Market Offering
Total proceeds from offerings of common stock and pre-funded warrants, net of underwriting discounts and commissions
Payments of public offering costs
Proceeds from issuance of common stock upon exercise of stock options and employee stock purchase plan
Proceeds from issuance of notes payable, net of issuance costs
Repayments of notes payable
Net cash provided by financing activities

Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Supplemental cash flow information:
Cash paid for taxes
Supplemental disclosure and noncash investing and financing information:
Purchases of property and equipment included in accounts payable and accrued expenses
Conversion of stock, amount converted
Issuance of warrants in connection with notes payable
Asset acquired in finance lease

Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents
Restricted cash (current and non-current)

Comments